These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 11367170)
1. Adefovir: FDA committee votes against approval. Food and Drug Administration. James JS AIDS Treat News; 1999 Nov; (No 330):1-2. PubMed ID: 11367170 [TBL] [Abstract][Full Text] [Related]
2. FDA panel fails to recommend adefovir approval. Food and Drug Administration. Highleyman L BETA; 1999; 12(4):4. PubMed ID: 11367249 [TBL] [Abstract][Full Text] [Related]
6. Adefovir dipivoxil (Preveon) expanded access restrictions being eased. James JS AIDS Treat News; 1998 Feb; (No 288):4-5. PubMed ID: 11365045 [TBL] [Abstract][Full Text] [Related]
7. FDA grants tentative approval to first generic version of antiretroviral Viread. AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039 [No Abstract] [Full Text] [Related]
8. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James. Feigal D AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399 [TBL] [Abstract][Full Text] [Related]
9. FDA notifications. FDA's tentative approval for generic Tenofovir. AIDS Alert; 2008 Jan; 23(1):11-2. PubMed ID: 18572475 [No Abstract] [Full Text] [Related]
10. FDA approves Viread for HIV-1 infection. FDA Consum; 2002; 36(1):5. PubMed ID: 11881601 [No Abstract] [Full Text] [Related]
11. Adefovir dipivoxil: new preparation. A third-line option in chronic hepatitis B. Prescrire Int; 2004 Feb; 13(69):4-7. PubMed ID: 15055205 [TBL] [Abstract][Full Text] [Related]
14. Tenofovir: Gilead applies for approval; expanded access liberalized. Gilden D AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959 [TBL] [Abstract][Full Text] [Related]
15. Tenofovir for the treatment of hepatitis B virus. Jenh AM; Thio CL; Pham PA Pharmacotherapy; 2009 Oct; 29(10):1212-27. PubMed ID: 19792994 [TBL] [Abstract][Full Text] [Related]
16. Testimony on accelerated approval. Hogan C GMHC Treat Issues; 2003 Nov; 17(11):12. PubMed ID: 14717108 [TBL] [Abstract][Full Text] [Related]
17. Tenofovir: FDA hearing October 3, public comment deadlines September 26. James JS AIDS Treat News; 2001 Aug; (370):3-4. PubMed ID: 11570163 [No Abstract] [Full Text] [Related]